Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU (PORPOISE-REA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03529058

Recruitment Status : Completed

First Posted : May 18, 2018

Last Update Posted : May 18, 2018

Sponsor:

Information provided by (Responsible Party):

University Hospital, Brest

Tracking Information

First Submitted Date

April 5, 2018

First Posted Date

May 18, 2018

Last Update Posted Date

May 18, 2018

Actual Study Start Date

November 26, 2017

Actual Primary Completion Date

March 31, 2018 (Final data collection date for primary outcome measure)

Current Primary Outcome Measures

90-day mortality [ Time Frame: 90 days since the first blood stream infection in ICU ]

Original Primary Outcome Measures

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures

Not Provided

Original Secondary Outcome Measures

Not Provided

Current Other Pre-specified Outcome Measures

Not Provided

Original Other Pre-specified Outcome Measures

Not Provided

Descriptive Information

Brief Title

Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

Official Title

Evaluation of Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

Brief Summary

Retrospective study in the 3 intensive care units of the Brest Teaching Hospital (France) during a 18-months period (June 2014 -December 2015) to study the independent association between hypophosphatemia and 90-day mortality.

Detailed Description

Not Provided

Study Type

Observational

Study Design

Observational Model: Cohort
Time Perspective: Retrospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

All patients admitted to 21-bed medical ICU, 15-bed surgical ICU and 8-bed cardiothoracic ICU between June 1, 2014 and December 31, 2015 were screened for inclusion.

Condition

Hypophosphatemia
Infection

Intervention

Not Provided

Study Groups/Cohorts

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status

Completed

Actual Enrollment

193

Original Actual Enrollment

Same as current

Actual Study Completion Date

March 31, 2018

Actual Primary Completion Date

March 31, 2018 (Final data collection date for primary outcome measure)

Eligibility Criteria

Inclusion Criteria:

Blood stream infection

Exclusion Criteria:

Less than 18 years old

Sex/Gender

Sexes Eligible for Study:

All

Ages

18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Contacts

Contact information is only displayed when the study is recruiting subjects

Listed Location Countries

France

Removed Location Countries

Administrative Information

NCT Number

NCT03529058

Other Study ID Numbers

PORPOISE-REA ( 29BRC17.0180)

Has Data Monitoring Committee

U.S. FDA-regulated Product

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

IPD Sharing Statement

Not Provided

Responsible Party

University Hospital, Brest

Study Sponsor

University Hospital, Brest

Collaborators

Not Provided

Investigators

Not Provided

PRS Account

University Hospital, Brest

Verification Date

November 2017

To Top